Search results
Results From The WOW.Com Content Network
Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium Streptococcus agalactiae. Streptococcus agalactiae is the most common human pathogen belonging to group B of the Lancefield classification of streptococci —hence the name of group B ...
The plural term group B streptococci (referring to the serotypes) and the singular term group B streptococcus (referring to the single species) are both commonly used synonymously with S. agalactiae even though S. halichoeri and S. pseudoporcinus are also group B Streptococci. These species test positive as group B, but are not frequently ...
Similarly, group B streptococcus typically denotes Streptococcus agalactiae, although minor beta-hemolytic group B streptococci like S. troglodytidis exist. [15] While most streptococcal illnesses in humans originate from species adapted to humans, such as S. pneumoniae or S. pyogenes, there are zoonotic species capable of causing infections. [15]
S. agalactiae, or group B streptococcus, GBS, causes pneumonia and meningitis in newborns and the elderly, with occasional systemic bacteremia. Importantly, Streptococcus agalactiae is the most common cause of meningitis in infants from one month to three months old.
Bacteria of the genus Enterococcus, formerly known as group D streptococci, were classified as members of the genus Streptococcus until 1984 and are included in the original Lancefield grouping. [4] Many—but not all—species of streptococcus are beta-hemolytic .
Granada medium is a selective and differential culture medium designed to selectively isolate Streptococcus agalactiae (Group B streptococcus, GBS) and differentiate it from other microorganisms. Granada Medium was developed by Manuel Rosa-Fraile et al. at the Service of Microbiology in the Hospital Virgen de las Nieves in Granada (Spain).
The CAMP test (Christie–Atkins–Munch-Petersen) is a test to identify group B β-hemolytic streptococci (Streptococcus agalactiae) [1] [2] based on their formation of a substance, CAMP factor, [3] that enlarges the area of hemolysis formed by the β-hemolysin elaborated from Staphylococcus aureus.
Group B Strep Support was formed in 1996, after the founders' son had a group B Strep infection. [1] Since then it has established a medical panel [ 2 ] and set up a board of trustees. [ 1 ] The charity has been heavily involved in public consultations on group B Strep prevention, and in 2012 commented on the National Screening Committee's ...